Incretin-based therapy in type 2 diabetes: An evidence based systematic review and meta-analysis
Waldrop G, Zhong J, Peters M, Goud A, Chen Y, Davis S, Mukherjee B, Rajagopalan S. Incretin-based therapy in type 2 diabetes: An evidence based systematic review and meta-analysis. Journal Of Diabetes And Its Complications 2016, 32: 113-122. PMID: 29074120, DOI: 10.1016/j.jdiacomp.2016.08.018.Peer-Reviewed Original ResearchMeSH KeywordsBlood GlucoseClinical Trials as TopicDiabetes Mellitus, Type 2Dipeptidyl-Peptidase IV InhibitorsDrug Therapy, CombinationHumansHypoglycemic AgentsIncretinsConceptsDipeptidyl peptidase-4 inhibitorsOral anti-diabetic agentsGLP-1RABackground therapyGlycemic efficacyWeight lossGlucagon-like peptide-1 receptor agonistsPeptide-1 receptor agonistsActive comparator armLong-acting GLP-1RAType 2 diabetes mellitusPeptidase-4 inhibitorsTreatment of type 2 diabetes mellitusIncretin-based therapiesActive comparator drugShort-acting agentsWeight loss effectsClinical trial evidenceType 2 diabetesRandomized controlled trialsReceptor agonistsAnti-diabetic agentsIncretin therapiesComparator armComparator therapy